Compare Stocks

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HLS HLS Therapeutics	C$4.92 +0.6%	C$4.23	C$3.34 ▼ C$7.12	C$157.05M	1.16	9,973 shs	601 shs
OGI Organigram	$1.91 +2.1%	$2.10	$0.97 ▼ $2.91	$197.11M	1.09	1.37 million shs	447,596 shs
PRN Invesco Dorsey Wright Industrials Momentum ETF	$131.00 -0.3%	$133.94	$90.63 ▼ $142.46	$214.84M	1.07	10,509 shs	3,501 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HLS HLS Therapeutics	+0.61%	-1.80%	+21.48%	+21.48%	-18.00%
OGI Organigram	+2.19%	-8.78%	-15.77%	+0.54%	-14.77%
PRN Invesco Dorsey Wright Industrials Momentum ETF	-0.75%	-4.64%	-2.42%	+12.33%	+40.14%

The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HLS HLS Therapeutics	0.0452 of 5 stars	1.1	0.0	1.7	0.0	0.4	0.8	0.0
OGI Organigram	0.2146 of 5 stars	0.0	2.0	0.0	0.0	2.5	0.0	1.3
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HLS HLS Therapeutics	2.25	Hold	C$4.58	-7.01% Downside
OGI Organigram	3.00	Buy	N/A	N/A
PRN Invesco Dorsey Wright Industrials Momentum ETF	0.00	N/A	$132.42	1.09% Upside

Current Analyst Ratings

Latest PRN, HLS, and OGI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/15/2024	OGI Organigram	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy
3/18/2024	HLS HLS Therapeutics	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$6.50 ➝ C$5.00
3/15/2024	HLS HLS Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$4.35 ➝ C$4.15
2/22/2024	HLS HLS Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$5.00 ➝ C$4.35
2/6/2024	HLS HLS Therapeutics	Clarus Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HLS HLS Therapeutics	C$63.07M	2.49	C$0.32 per share	15.22	C$3.06 per share	1.61
OGI Organigram	$120.01M	1.64	N/A	N/A	$2.48 per share	0.77
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HLS HLS Therapeutics	-C$27.53M	-C$1.16	N/A	∞	N/A	-43.65%	-24.69%	-2.87%	5/9/2024 (Estimated)
OGI Organigram	-$184.34M	-$0.80	N/A	N/A	N/A	-173.48%	-30.94%	-27.70%	4/23/2024 (Estimated)
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A	N/A	30.27	∞	N/A	N/A	N/A	N/A	N/A

Latest PRN, HLS, and OGI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/14/2024	Q4 2023	HLS HLS Therapeutics	-C$0.13	-C$0.18	-C$0.05	-C$0.13	C$21.83 million	C$21.60 million
2/13/2024	Q1 2024	OGI Organigram	-$0.10	-$0.14	-$0.04	-$0.14	$28.61 million	$26.78 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HLS HLS Therapeutics	C$0.20	4.07%	N/A	N/A	N/A
OGI Organigram	N/A	N/A	N/A	N/A	N/A
PRN Invesco Dorsey Wright Industrials Momentum ETF	$0.48	0.37%	N/A	N/A	N/A

Latest PRN, HLS, and OGI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/15/2024	PRN Invesco Dorsey Wright Industrials Momentum ETF	Quarterly	$0.0727		3/18/2024	3/19/2024	3/22/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HLS HLS Therapeutics	89.69	1.65	1.01
OGI Organigram	N/A	4.28	2.11
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
HLS HLS Therapeutics	59.62%
OGI Organigram	34.63%
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A

Insider Ownership

Company	Insider Ownership
HLS HLS Therapeutics	0.49%
OGI Organigram	0.09%
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
HLS HLS Therapeutics	91	31.92 million	N/A	Not Optionable
OGI Organigram	984	103.20 million	103.11 million	Optionable
PRN Invesco Dorsey Wright Industrials Momentum ETF	N/A	1.64 million	N/A	Optionable

PRN, HLS, and OGI Headlines

Source	Headline
	Top-Ranked ETFs That Outperformed the Market in Q1 zacks.com - April 2 at 11:01 AM
	Buy 5 Top-Ranked ETFs to Play Broadening US Market Rally zacks.com - March 25 at 2:01 PM
	Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)? zacks.com - March 20 at 7:21 AM
	5 Top-Ranked ETFs at New Highs Set to Soar Further zacks.com - March 4 at 12:11 PM
	PRN - Invesco DWA Industrials Momentum ETF finance.yahoo.com - August 20 at 5:51 PM
	Invesco DWA Basic Materials Momentum ETF declares quarterly distribution of $0.2133 seekingalpha.com - June 21 at 3:02 PM
	Invesco DWA Industrials Momentum ETF declares quarterly distribution of $0.2963 msn.com - December 22 at 6:05 PM
	PXI: A Good Moment To Buy This Energy Momentum ETF seekingalpha.com - December 19 at 12:40 PM
	PTF Invesco Exchange-Traded Fund Trust - Invesco DWA Technology Momentum ETF seekingalpha.com - September 20 at 3:52 PM
	Invesco DWA Industrials Momentum ETF declares quarterly distribution of $0.1191 seekingalpha.com - June 21 at 3:51 PM
	Analysts Anticipate PRN To Hit $109 nasdaq.com - May 9 at 10:13 AM
	Sum Up The Parts: PRN Could Be Worth $117 nasdaq.com - March 28 at 8:36 AM
	Analyst Ratings For Invesco markets.businessinsider.com - February 18 at 12:45 PM
	The Invesco DWA Industrials Momentum ETF Continues its Poor Performance finance.yahoo.com - December 15 at 9:44 AM
	5 Top-Ranked ETFs That Outperformed the Market in October entrepreneur.com - November 3 at 6:34 PM
	The Most Common Passive-Aggressive Phrases People Say At Work yahoo.com - October 15 at 6:24 AM
	Should You Invest in the Invesco DWA Industrials Momentum ETF (PRN)? finance.yahoo.com - August 2 at 9:47 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

HLS Therapeutics

TSE:HLS

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

Organigram

NASDAQ:OGI

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Invesco Dorsey Wright Industrials Momentum ETF

NASDAQ:PRN

PowerShares Dynamic Industrials Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Industrials Sector Intellidex Index (the Index). The Index consists of stocks of 60 United States industrial companies. These are companies that are principally engaged in the business of providing industrial products and services, including engineering, heavy machinery, construction, electrical equipment, aerospace and defense, and general manufacturing. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial